CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling

Shun Xu1,2, Jin Wang2, Junjie Zhong3,4,5,6

  • 1Department of Orthopedics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.

Abstract

Insights

CD73, an immunosuppressive molecule, inhibits microglia pyroptosis by suppressing gasdermin D (GSDMD) maturation. This finding offers a potential therapeutic strategy for spinal cord injury (SCI) by targeting neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Spinal cord injury (SCI) progression is often driven by secondary injury mechanisms, including neuroinflammation.
  • Pyroptosis, a form of inflammatory programmed cell death mediated by gasdermin D (GSDMD), is a key component of neuroinflammation.
  • The role of the immunosuppressive molecule CD73 in regulating pyroptosis, particularly via GSDMD, remains largely unexplored.

Purpose of the Study:

  • To investigate the effect of CD73 on microglia pyroptosis in the context of spinal cord injury.
  • To elucidate the molecular mechanisms by which CD73 modulates pyroptosis and GSDMD activation.
  • To explore the potential of CD73 as a therapeutic target for SCI.

Main Methods:

  • Utilized CD73 deficient and wild-type mice, along with LPS-induced primary microglia and BV2 cell lines for in vivo and in vitro studies.
  • Employed a combination of molecular biology and histological techniques to assess pyroptosis and investigate underlying mechanisms.
  • Analyzed the role of the adenosine-A2B receptor-PI3K-AKT-Foxo1 pathway and HIF-1α in CD73-mediated regulation.

Main Results:

  • Demonstrated that CD73 suppresses NLRP3 inflammasome activation, reducing GSDMD maturation and subsequent pyroptosis in microglia.
  • Identified the adenosine-A2B receptor-PI3K-AKT-Foxo1 cascade as a key pathway in CD73's regulatory mechanism.
  • Confirmed that CD73 inhibits GSDMD expression transcriptionally via Foxo1 and established a positive feedback loop involving HIF-1α and CD73 in SCI.

Conclusions:

  • Revealed a novel inhibitory function of CD73 on microglia pyroptosis, distinct from its known immunosuppressive roles.
  • Highlighted the therapeutic potential of targeting CD73 to mitigate neuroinflammation and secondary injury in spinal cord injury.
  • Established a new regulatory axis involving CD73, GSDMD, and HIF-1α in the context of SCI pathogenesis.

Related Concept Videos